Current and Emerging Treatments for Urothelial Carcinoma: A Focus on Enfortumab Vedotin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current and Emerging Treatments for Urothelial Carcinoma: A Focus on Enfortumab Vedotin

Published:2023-07 Issue: Volume:Volume 15 Page:699-706
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Shafique Muhammad Ashir^ORCID,Haseeb Abdul^ORCID,Siddiq Mohammad Arham^ORCID,Mussarat Abdullah^ORCID,Rangwala Hussain Sohail^ORCID,Mustafa Muhammad Saqlain^ORCID

Publisher

Informa UK Limited

Subject

Oncology

Reference53 articles.

1. National and State Estimates of Lost Earnings From Cancer Deaths in the United States

2. Evaluation of Vitamin E and Selenium Supplementation for the Prevention of Bladder Cancer in SWOG Coordinated SELECT

3. Epidemiology of Bladder Cancer

4. Epidemiology of urothelial carcinoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-marketing drug safety surveillance of enfortumab vedotin: an observational pharmacovigilance study based on a real-world database;Frontiers in Immunology;2024-08-20

2. CXCL10 could be a prognostic and immunological biomarker in bladder cancer;2024-02-06

3. Current and Emerging Strategies to Treat Urothelial Carcinoma;Cancers;2023-10-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP